CCHR Marks 22 Years of Federal Protections Against Forced Psychiatric Drugging of Students

LOS ANGELES — As the debate over psychiatric drug use in children intensifies, the Citizens Commission on Human Rights International (CCHR) is reminding the public of a federal protection it helped secure two decades ago. The Prohibition on Mandatory Medication Amendment, now part of the Code of Federal Regulations, prevents schools from requiring parents to place children on psychiatric drugs as a condition of attending school. This law, enacted in 2004, was a direct response to widespread reports of school officials coercing parents through threats of expulsion, involvement of Child Protective Services, or accusations of medical neglect.

The need for such legislation was underscored by families who watched their children suffer severe side effects from these medications, with some children and teens dying by suicide while taking them. CCHR, a mental health industry watchdog, played a pivotal role in bringing these issues to Congress. At the time, Congressman Dan Burton, Chairman of the Government Reform Committee, praised CCHR's efforts, stating, "Through united action, effective education and advocacy, CCHR has helped to bring about critically needed healthcare reform." A senior staffer on the Committee echoed this sentiment, noting that CCHR's most significant impact was raising awareness on Capitol Hill about the coercive practices occurring in schools.

The fight for transparency and protection has been long and arduous. CCHR was the first patient advocacy group to pressure the Food and Drug Administration (FDA) to convene a public hearing in 1991 to investigate antidepressant-induced suicide and violence. Despite testimony from dozens of patients and family members, the FDA's advisory panel, many of whom had financial ties to pharmaceutical companies, voted against any label change. It took another 13 years of relentless advocacy before the FDA added black-box warnings about suicidal ideation to SSRI antidepressants.

Recent government actions signal a shift in recognizing the risks associated with psychiatric drugs. In May 2026, the U.S. Department of Health and Human Services announced initiatives to curb psychiatric overprescribing and assist those wishing to withdraw safely from these drugs, particularly antidepressants. On July 24, 2026, Florida Surgeon General Dr. Joseph A. Ladapo issued guidance recommending against the use of psychotropic drugs in children for mental health conditions, emphasizing the importance of a full physical examination before initiating any treatment. This aligns with CCHR's long-standing advocacy for physical health checks, dating back to its formation in 1969 and its Mental Health Declaration of Human Rights.

CCHR's work has been supported by notable figures, including the late actresses Kirstie Alley and Kelly Preston, both of whom served on CCHR International's board of Commissioners and testified before the Florida state legislature in 2005. Their advocacy helped pass similar prohibitions in 12 states, building momentum for the federal effort.

Jan Eastgate, President of CCHR International, emphasized the importance of these protections, stating, "The risk data was always available for anyone willing to listen to patients or press for the facts, and thanks to those who did, there is a cultural shift in the recognition of psychotropic drug risks and the need to be able to safely withdraw from them. They should never be forced onto any child or individual."

As the conversation around mental health treatment evolves, CCHR continues to serve as a watchdog, ensuring that the rights of parents and children are protected. The organization, established by the Church of Scientology and psychiatrist Dr. Thomas Szasz, has helped enact more than 190 reforms worldwide. For those seeking accountability and protection from coercive psychiatric practices, CCHR remains a resource.